Venus Remedies Limited has informed the Exchange regarding 'Declarartion of Dividend'.
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Venus Remedies Limited has declared a final dividend of Rs. 10 per equity share (100% on face value of Rs. 10) for FY 2025-26, subject to shareholder approval at the 37th AGM on August 20, 2026. The record date to determine eligible shareholders is August 7, 2026. The company reported strong financial performance with standalone revenue from operations of Rs. 768.73 crore (up 19% from Rs. 644.47 crore) and net profit of Rs. 99.31 crore (up 89% from Rs. 52.55 crore). Consolidated net profit stood at Rs. 102.78 crore, nearly doubling from Rs. 45.31 crore in the previous year. EPS for standalone was Rs. 74.29 compared to Rs. 39.32 in FY 2024-25.
The company has delivered exceptional profit growth of nearly 90% year-on-year, and the dividend declaration signals confidence in financial health. This positive earnings beat and shareholder-friendly payout should be viewed favorably by investors, potentially supporting the stock price ahead of the record date.